Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1627

Similar articles for PubMed (Select 14718543)

1.

p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.

Hu MC, Wasserman D, Hartwig S, Rosenblum ND.

J Biol Chem. 2004 Mar 26;279(13):12051-9. Epub 2004 Jan 12.

2.

Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis.

Leung-Hagesteijn C, Hu MC, Mahendra AS, Hartwig S, Klamut HJ, Rosenblum ND, Hannigan GE.

Mol Cell Biol. 2005 May;25(9):3648-57.

4.

BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways.

Piscione TD, Phan T, Rosenblum ND.

Am J Physiol Renal Physiol. 2001 Jan;280(1):F19-33.

5.

Protein kinase A is a negative regulator of renal branching morphogenesis and modulates inhibitory and stimulatory bone morphogenetic proteins.

Gupta IR, Piscione TD, Grisaru S, Phan T, Macias-Silva M, Zhou X, Whiteside C, Wrana JL, Rosenblum ND.

J Biol Chem. 1999 Sep 10;274(37):26305-14.

6.

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

Lavoie JN, L'Allemain G, Brunet A, Müller R, Pouysségur J.

J Biol Chem. 1996 Aug 23;271(34):20608-16.

7.

p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL.

J Cell Sci. 2002 Aug 1;115(Pt 15):3193-206.

8.
9.

BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis.

Gupta IR, Macias-Silva M, Kim S, Zhou X, Piscione TD, Whiteside C, Wrana JL, Rosenblum ND.

J Cell Sci. 2000 Jan;113 Pt 2:269-78.

10.

Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.

Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL.

J Biol Chem. 1998 Oct 2;273(40):25628-36.

11.
13.

TNF-alpha inhibits SP-A gene expression in lung epithelial cells via p38 MAPK.

Miakotina OL, Snyder JM.

Am J Physiol Lung Cell Mol Physiol. 2002 Aug;283(2):L418-27.

15.

Mediation of BMP7 neuroprotection by MAPK and PKC IN rat primary cortical cultures.

Cox S, Harvey BK, Sanchez JF, Wang JY, Wang Y.

Brain Res. 2004 Jun 4;1010(1-2):55-61.

PMID:
15126117
16.

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS.

Mol Pharmacol. 2002 Jul;62(1):65-74.

17.

The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.

Fu Y, O'Connor LM, Shepherd TG, Nachtigal MW.

Biochem Biophys Res Commun. 2003 Oct 17;310(2):391-7.

PMID:
14521923
18.

Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.

Robinson AJ, Dickenson JM.

Eur J Pharmacol. 2001 Feb 16;413(2-3):151-61.

PMID:
11226388
19.

p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.

He Z, Cho YY, Liu G, Ma WY, Bode AM, Dong Z.

J Biol Chem. 2003 Jul 18;278(29):26435-42. Epub 2003 May 13.

20.

Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H, Doihara H.

J Endocrinol. 2008 Dec;199(3):445-55. doi: 10.1677/JOE-08-0226. Epub 2008 Sep 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk